In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
The NHS invests an additional £5 million to fund reviews improve care for people with a learning disability and emphasise their commitment to tackling serious national issues.
A new tool designed to help healthcare professionals boost diabetes referrals to structured education courses is being announced by Diabetes UK and Kent and Medway STP.
Numbers have reached record highs with over 870,000 clinical trial participants involved in research studies supported by the National Institute for Health Research (NIHR) over the last year.
An army of experts have been recruited by NHS England to stop overmedication of care home residents, aiming to improve older people’s health and care under the NHS Long Term Plan.
UK patients are looking to European destinations such as Lithuania, where world-class medical care can be carried out quicker, privately, and at a much lower cost.
Diabetes UK and JDRF have announced their continued commitment to revolutionising Type 1 diabetes treatment, by awarding £490,000 to fund the next generation of immunotherapy research.
Department of Health and Social Care announces improvements to the Accelerated Access Collaborative (AAC) that will put the most promising medicines, diagnostic tools and digital services through clinical development and regulatory processes faster.
Dr. Lynne Green speaks to Nishat from Open Access Government about NHS eating disorder treatment, what to do if someone is suffering, and how social media has changed the landscape.
Laura Kirschbacher, Corporate Communications Manager at Pfalzklinikum AdöR talks about ward-equivalent treatment (WeT), a special kind of hometreatment, where a multi-professional team visits the patients at home: She accompanied WeT social worker Linda Seez to find out more.
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
THz and millimetre wave frequency techniques, combined with thin film measurement methods, provide early detection of corneal edema associated with disease in the view of Zachary Taylor, Assistant Professor at Aalto University.
